Limited Utility of Serology and Heterophile Test in the Early Diagnosis of Epstein–Barr Virus Mononucleosis in a Child after Renal Transplantation

<b>Background:</b> Epstein–Barr virus (EBV) infection is associated with significant morbidity and mortality in renal transplant (RT) recipients. The spectrum of illness ranges from infectious mononucleosis (IM) to post-transplant lymphoproliferative disorder (PTLD). In association with...

Full description

Bibliographic Details
Main Authors: Alexandra Byrne, Rachel Bush, Felicia Johns, Kiran Upadhyay
Format: Article
Language:English
Published: MDPI AG 2020-04-01
Series:Medicines
Subjects:
Online Access:https://www.mdpi.com/2305-6320/7/4/21
_version_ 1797569944485888000
author Alexandra Byrne
Rachel Bush
Felicia Johns
Kiran Upadhyay
author_facet Alexandra Byrne
Rachel Bush
Felicia Johns
Kiran Upadhyay
author_sort Alexandra Byrne
collection DOAJ
description <b>Background:</b> Epstein–Barr virus (EBV) infection is associated with significant morbidity and mortality in renal transplant (RT) recipients. The spectrum of illness ranges from infectious mononucleosis (IM) to post-transplant lymphoproliferative disorder (PTLD). In association with clinical signs and symptoms, virus-specific serology and heterophile antibody tests are widely used in confirming the diagnosis of IM in the general population. However, these tests may have a limited role in immunosuppressed RT recipients from seropositive donor, especially in children who were EBV-seronegative prior to the transplant. The aim of this study is to evaluate the utility of these tests in the early diagnosis of IM in this subset of patients. <b>Methods:</b> This is a case study with a review of literature. <b>Results:</b> Here, we present a 14-year-old male with hemophilia B who presented with fever, fatigue, sore throat, palatal petechial rash, exudative tonsillitis and cervical lymphadenopathy 3 months post-RT. He was EBV seronegative prior to RT and received a deceased donor kidney transplant from a seropositive donor. Induction was done with Thymoglobulin and maintenance immunosuppression consisted of tacrolimus and mycophenolate. Initial heterophile antibody test (monospot) was negative, but became positive at 5 months and remained positive at 9 months follow-up post-RT. EBV viral capsid antigens (VCA) IgM and IgG, early antigen (EA) and nuclear antigen (EBNA) were all negative at the time of presentation. VCA IgM and IgG both became positive at 5 months and peaked at 9 months follow-up, however the EA and EBNA remained negative. EBV viral load as measured by polymerase chain reaction (PCR) was negative for the first 3 months post-RT but became positive at presentation, peaked at 6 months and started declining thereafter. Peripheral blood smear examination showed no absolute and atypical lymphocytosis. Cytomegalovirus PCR in the blood and throat culture for streptococcus were negative. There was no splenomegaly. He was managed conservatively with intravenous fluids, bed rest, antipyretics and reduction of immunosuppression. <b>Conclusions:</b> EBV serological markers have a limited role in the early diagnosis of EBV-IM following RT in prior seronegative children. Initial heterophile antibody test may also be negative, and hence a repeat test may be necessary. Once becoming positive, the VCA IgM may remain persistently elevated for prolonged duration. In addition to the suppressed cellular immunity secondary to immunosuppression, humoral response to viral infections is also delayed in transplant recipients, especially in the early transplant period. Hence, routine monitoring with PCR is superior to serology in diagnosing IM early and monitoring the EBV infection post-RT for timely evaluation and management.
first_indexed 2024-03-10T20:18:25Z
format Article
id doaj.art-7424911ede21450ea620223d630595b8
institution Directory Open Access Journal
issn 2305-6320
language English
last_indexed 2024-03-10T20:18:25Z
publishDate 2020-04-01
publisher MDPI AG
record_format Article
series Medicines
spelling doaj.art-7424911ede21450ea620223d630595b82023-11-19T22:21:32ZengMDPI AGMedicines2305-63202020-04-01742110.3390/medicines7040021Limited Utility of Serology and Heterophile Test in the Early Diagnosis of Epstein–Barr Virus Mononucleosis in a Child after Renal TransplantationAlexandra Byrne0Rachel Bush1Felicia Johns2Kiran Upadhyay3Department of Pediatrics, University of Florida, Gainesville, FL 32610, USADivision of Pediatric Nephrology, Department of Pediatrics, University of Florida, Gainesville, FL 32610, USADivision of Pediatric Nephrology, Department of Pediatrics, University of Florida, Gainesville, FL 32610, USADivision of Pediatric Nephrology, Department of Pediatrics, University of Florida, Gainesville, FL 32610, USA<b>Background:</b> Epstein–Barr virus (EBV) infection is associated with significant morbidity and mortality in renal transplant (RT) recipients. The spectrum of illness ranges from infectious mononucleosis (IM) to post-transplant lymphoproliferative disorder (PTLD). In association with clinical signs and symptoms, virus-specific serology and heterophile antibody tests are widely used in confirming the diagnosis of IM in the general population. However, these tests may have a limited role in immunosuppressed RT recipients from seropositive donor, especially in children who were EBV-seronegative prior to the transplant. The aim of this study is to evaluate the utility of these tests in the early diagnosis of IM in this subset of patients. <b>Methods:</b> This is a case study with a review of literature. <b>Results:</b> Here, we present a 14-year-old male with hemophilia B who presented with fever, fatigue, sore throat, palatal petechial rash, exudative tonsillitis and cervical lymphadenopathy 3 months post-RT. He was EBV seronegative prior to RT and received a deceased donor kidney transplant from a seropositive donor. Induction was done with Thymoglobulin and maintenance immunosuppression consisted of tacrolimus and mycophenolate. Initial heterophile antibody test (monospot) was negative, but became positive at 5 months and remained positive at 9 months follow-up post-RT. EBV viral capsid antigens (VCA) IgM and IgG, early antigen (EA) and nuclear antigen (EBNA) were all negative at the time of presentation. VCA IgM and IgG both became positive at 5 months and peaked at 9 months follow-up, however the EA and EBNA remained negative. EBV viral load as measured by polymerase chain reaction (PCR) was negative for the first 3 months post-RT but became positive at presentation, peaked at 6 months and started declining thereafter. Peripheral blood smear examination showed no absolute and atypical lymphocytosis. Cytomegalovirus PCR in the blood and throat culture for streptococcus were negative. There was no splenomegaly. He was managed conservatively with intravenous fluids, bed rest, antipyretics and reduction of immunosuppression. <b>Conclusions:</b> EBV serological markers have a limited role in the early diagnosis of EBV-IM following RT in prior seronegative children. Initial heterophile antibody test may also be negative, and hence a repeat test may be necessary. Once becoming positive, the VCA IgM may remain persistently elevated for prolonged duration. In addition to the suppressed cellular immunity secondary to immunosuppression, humoral response to viral infections is also delayed in transplant recipients, especially in the early transplant period. Hence, routine monitoring with PCR is superior to serology in diagnosing IM early and monitoring the EBV infection post-RT for timely evaluation and management.https://www.mdpi.com/2305-6320/7/4/21Epstein–Barr virusserologymononucleosisrenal transplantpediatric
spellingShingle Alexandra Byrne
Rachel Bush
Felicia Johns
Kiran Upadhyay
Limited Utility of Serology and Heterophile Test in the Early Diagnosis of Epstein–Barr Virus Mononucleosis in a Child after Renal Transplantation
Medicines
Epstein–Barr virus
serology
mononucleosis
renal transplant
pediatric
title Limited Utility of Serology and Heterophile Test in the Early Diagnosis of Epstein–Barr Virus Mononucleosis in a Child after Renal Transplantation
title_full Limited Utility of Serology and Heterophile Test in the Early Diagnosis of Epstein–Barr Virus Mononucleosis in a Child after Renal Transplantation
title_fullStr Limited Utility of Serology and Heterophile Test in the Early Diagnosis of Epstein–Barr Virus Mononucleosis in a Child after Renal Transplantation
title_full_unstemmed Limited Utility of Serology and Heterophile Test in the Early Diagnosis of Epstein–Barr Virus Mononucleosis in a Child after Renal Transplantation
title_short Limited Utility of Serology and Heterophile Test in the Early Diagnosis of Epstein–Barr Virus Mononucleosis in a Child after Renal Transplantation
title_sort limited utility of serology and heterophile test in the early diagnosis of epstein barr virus mononucleosis in a child after renal transplantation
topic Epstein–Barr virus
serology
mononucleosis
renal transplant
pediatric
url https://www.mdpi.com/2305-6320/7/4/21
work_keys_str_mv AT alexandrabyrne limitedutilityofserologyandheterophiletestintheearlydiagnosisofepsteinbarrvirusmononucleosisinachildafterrenaltransplantation
AT rachelbush limitedutilityofserologyandheterophiletestintheearlydiagnosisofepsteinbarrvirusmononucleosisinachildafterrenaltransplantation
AT feliciajohns limitedutilityofserologyandheterophiletestintheearlydiagnosisofepsteinbarrvirusmononucleosisinachildafterrenaltransplantation
AT kiranupadhyay limitedutilityofserologyandheterophiletestintheearlydiagnosisofepsteinbarrvirusmononucleosisinachildafterrenaltransplantation